These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
930 related articles for article (PubMed ID: 31234830)
1. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830 [TBL] [Abstract][Full Text] [Related]
2. Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia. Wu C; Cui J; Huo Y; Shi L; Wang C Int J Biol Macromol; 2023 May; 237():123990. PubMed ID: 36906205 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia. Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398 [TBL] [Abstract][Full Text] [Related]
4. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome. Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway. Zhuang XH; Liu Y; Li JL Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688 [TBL] [Abstract][Full Text] [Related]
6. CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia. Li S; Zhao G; Wu W; Li N; Wang Q; Wang W; Song X; Wang X Clin Exp Med; 2023 Dec; 23(8):4649-4664. PubMed ID: 37930606 [TBL] [Abstract][Full Text] [Related]
7. LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes. Li N; Ma Y; Wang W; Yin CC; Wu W; Sun R; Zhao G; Li S; Wang X Clin Sci (Lond); 2020 Jun; 134(11):1279-1293. PubMed ID: 32463458 [TBL] [Abstract][Full Text] [Related]
8. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J; Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590 [TBL] [Abstract][Full Text] [Related]
9. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression. Zhang XM; Chen H; Zhou B; Zhang QY; Liao Y; Wang JS; Wang ZH Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6784-6792. PubMed ID: 30402841 [TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis. Xu S; Jia G; Zhang H; Wang L; Cong Y; Lv M; Xu J; Ruan H; Jia X; Xu P; Wang Y Life Sci; 2021 Jan; 264():118636. PubMed ID: 33148416 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA (lncRNA) HOXB-AS3 promotes cell proliferation and inhibits apoptosis by regulating ADAM9 expression through targeting miR-498-5p in endometrial carcinoma. Xing Y; Sun X; Li F; Jiang X; Jiang A; Li X; Lv R; Shao L J Int Med Res; 2021 Jun; 49(6):3000605211013548. PubMed ID: 34187214 [TBL] [Abstract][Full Text] [Related]
13. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia. Zheng J; Song Y; Li Z; Tang A; Fei Y; He W Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Papaioannou D; Petri A; Dovey OM; Terreri S; Wang E; Collins FA; Woodward LA; Walker AE; Nicolet D; Pepe F; Kumchala P; Bill M; Walker CJ; Karunasiri M; Mrózek K; Gardner ML; Camilotto V; Zitzer N; Cooper JL; Cai X; Rong-Mullins X; Kohlschmidt J; Archer KJ; Freitas MA; Zheng Y; Lee RJ; Aifantis I; Vassiliou G; Singh G; Kauppinen S; Bloomfield CD; Dorrance AM; Garzon R Nat Commun; 2019 Nov; 10(1):5351. PubMed ID: 31767858 [TBL] [Abstract][Full Text] [Related]
15. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome. Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969 [TBL] [Abstract][Full Text] [Related]
16. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488 [TBL] [Abstract][Full Text] [Related]
17. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance. Chen XD; Zhu MX; Wang SJ Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100 [TBL] [Abstract][Full Text] [Related]
19. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC). Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309 [TBL] [Abstract][Full Text] [Related]
20. Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database. Enrico A; Bestach Y; Flores MG; Arbelbide J; Serale C; Novoa V; Crisp R; Rivas MM; Larripa I; Belli C Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):743-752.e5. PubMed ID: 28797621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]